Literature DB >> 27663755

Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.

Ryu Watanabe1, Ebru Hosgur1, Hui Zhang1, Zhenke Wen1, Gerald Berry2, Jörg J Goronzy1, Cornelia M Weyand3.   

Abstract

Giant cell arteritis is an autoimmune disease defined by explicit tissue tropism to the walls of medium and large arteries. Pathognomic inflammatory lesions are granulomatous in nature, emphasizing the functional role of CD4T cells and macrophages. Evidence for a pathogenic role of antibodies and immune complexes is missing. Analysis of T cell populations in giant cell arteritis, both in the tissue lesions and in the circulation, has supported a model of broad, polyclonal T cell activation, involving an array of functional T cell lineages. The signature of T cell cytokines produced by vasculitic lesions is typically multifunctional, including IL-2, IFN-γ, IL-17, IL-21, and GM-CSF, supportive for a general defect in T cell regulation. Recent data describing the lack of a lymph node-based population of anti-inflammatory T cells in giant cell arteritis patients offers a fresh look at the immunopathology of this vasculitis. Due to defective CD8+NOX2+ regulatory T cells, giant cell arteritis patients appear unable to curtail clonal expansion within the CD4T cell compartment, resulting in widespread CD4T cell hyperimmunity. Why unopposed expansion of committed CD4 effector T cells would lead to invasion of the walls of medium and large arteries needs to be explored in further investigations.
Copyright © 2016 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory T cells; CD8(+) Treg cells; Giant cell arteritis; Macrophage; Pro-inflammatory T cells

Mesh:

Year:  2016        PMID: 27663755      PMCID: PMC5639893          DOI: 10.1016/j.jbspin.2016.07.005

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  53 in total

1.  Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  B Dasgupta; O Duke; A M Timms; C Pitzalis; G S Panayi
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

2.  Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.

Authors:  Mary Connolly; Alessandra Marrelli; Mark Blades; Jennifer McCormick; Paola Maderna; Catherine Godson; Ronan Mullan; Oliver FitzGerald; Barry Bresnihan; Costantino Pitzalis; Douglas J Veale; Ursula Fearon
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

Review 3.  Regulatory T cells in cancer immunotherapy.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2014-01-14       Impact factor: 7.486

4.  The sensitivity and specificity of reduced CD8 lymphocyte levels in the diagnosis of polymyalgia rheumatica/giant cell arteritis.

Authors:  M H Arnold; V M Corrigall; C Pitzalis; G S Panayi
Journal:  Clin Exp Rheumatol       Date:  1993 Nov-Dec       Impact factor: 4.473

5.  NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.

Authors:  Zhenke Wen; Yasuhiro Shimojima; Tsuyoshi Shirai; Yinyin Li; Jihang Ju; Zhen Yang; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

6.  Involvement and prognosis value of CD8(+) T cells in giant cell arteritis.

Authors:  Maxime Samson; Kim Heang Ly; Benjamin Tournier; Nona Janikashvili; Malika Trad; Marion Ciudad; Alexandrine Gautheron; Hervé Devilliers; Valérie Quipourt; François Maurier; Nadine Meaux-Ruault; Nadine Magy-Bertrand; Patrick Manckoundia; Paul Ornetti; Jean-Francis Maillefert; Jean-François Besancenot; Christophe Ferrand; Laura Mesturoux; François Labrousse; Anne-Laure Fauchais; Philippe Saas; Laurent Martin; Sylvain Audia; Bernard Bonnotte
Journal:  J Autoimmun       Date:  2016-05-25       Impact factor: 7.094

Review 7.  Inhibition of IL-17 as a pharmacological approach for IBD.

Authors:  Leo R Fitzpatrick
Journal:  Int Rev Immunol       Date:  2013-07-25       Impact factor: 5.311

8.  Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.

Authors:  N E Roche; J W Fulbright; A D Wagner; G G Hunder; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1993-09

9.  Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.

Authors:  C Salvarani; L Boiardi; P Macchioni; F Rossi; P Tartoni; M Casadei Maldini; R Mancini; E Beltrandi; I Portioli
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

Review 10.  Granulomatous inflammation: The overlap of immune deficiency and inflammation.

Authors:  Carlos D Rose; Benedicte Neven; Carine Wouters
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-04       Impact factor: 4.098

View more
  19 in total

Review 1.  Immune checkpoint dysfunction in large and medium vessel vasculitis.

Authors:  Ryu Watanabe; Hui Zhang; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

Review 2.  The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.

Authors:  Cornelia M Weyand; Gerald J Berry; Jörg J Goronzy
Journal:  J Leukoc Biol       Date:  2017-12-29       Impact factor: 4.962

3.  Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.

Authors:  Hui Zhang; Ryu Watanabe; Gerald J Berry; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2017-12-18       Impact factor: 29.690

Review 4.  Giant Cell Arteritis: Practical Pearls and Updates.

Authors:  Swati Pradeep; Jonathan H Smith
Journal:  Curr Pain Headache Rep       Date:  2018-01-17

5.  Cytokines, growth factors and proteases in medium and large vessel vasculitis.

Authors:  Cornelia M Weyand; Ryu Watanabe; Hui Zhang; Mitsuhiro Akiyama; Gerald J Berry; Jörg J Goronzy
Journal:  Clin Immunol       Date:  2019-02-14       Impact factor: 3.969

Review 6.  Redox-sensitive signaling in inflammatory T cells and in autoimmune disease.

Authors:  Cornelia M Weyand; Yi Shen; Jorg J Goronzy
Journal:  Free Radic Biol Med       Date:  2018-03-07       Impact factor: 7.376

Review 7.  Vasculitogenic T Cells in Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Motomu Hashimoto
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

8.  An unusual case of aortic rupture after deployment of a bare stent in the treatment of aortic dissection in a patient with giant-cell arteritis.

Authors:  Pawel Rynio; Arkadiusz Kazimierczak; Piotr Gutowski; Miloslaw Cnotliwy
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-05-12       Impact factor: 1.195

9.  Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.

Authors:  Joseph J Maleszewski; Brian R Younge; John T Fritzlen; Gene G Hunder; Jorg J Goronzy; Kenneth J Warrington; Cornelia M Weyand
Journal:  Mod Pathol       Date:  2017-03-03       Impact factor: 7.842

Review 10.  Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences.

Authors:  Ryu Watanabe; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.